article thumbnail

Government of Canada invests in clinical trial development in Canada through the Clinical Trials Fund

Pharma in Brief

On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The Clinical Trials Fund.

article thumbnail

Reducing lung transplant rejection aim of clinical trial funded with $22 million grant

Scienmag

Physicians at Washington University School of Medicine in St.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Oral immunotherapy induces remission of peanut allergy in some young children

Scienmag

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth. The immunotherapy consisted of a daily oral dose of peanut flour for 2.5

article thumbnail

NIH expands clinical trials to test convalescent plasma against COVID-19

Scienmag

Rigorous studies to build on earlier efforts to test the experimental treatment Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19.

article thumbnail

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy

pharmaphorum

Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. For now, analysis of the safety and mortality data from ACTT-2 are still ongoing, according to the president of Lilly Bio-Medicines, Patrik Jonsson.

Trials 111
article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. 13 in the New England Journal of Medicine , involved patients with high blood pressure in the lungs caused by interstitial lung disease (ILD). FRIDAY, Jan.

Doctors 52
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

After all, the EU Beating Cancer Plan was initiated before the pandemic and the tools that exist now – precision medicine, high-performance computing, AI – all of these are essentials for equitable access and innovative medicine. And in the UK over 30% of clinical trials funded has one European partner at least.

Nurses 97